Join

Compare · PHR vs RELX

PHR vs RELX

Side-by-side comparison of Phreesia Inc. (PHR) and RELX PLC PLC (RELX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both PHR and RELX operate in Real Estate (Real Estate), so they compete in similar markets.
  • RELX is the larger of the two at $66.74B, about 119.3x PHR ($559.6M).
  • Over the past year, PHR is down 61.9% and RELX is down 32.1% - RELX leads by 29.9 points.
  • PHR has been more active in the news (23 items in the past 4 weeks vs 9 for RELX).
  • PHR has more recent analyst coverage (25 ratings vs 10 for RELX).
PerformancePHR-61.93%RELX-32.06%
2025-05-01+0.00%2026-05-01
MetricPHRRELX
Company
Phreesia Inc.
RELX PLC PLC
Price
$9.60+4.35%
$36.72+0.34%
Market cap
$559.6M
$66.74B
1M return
+14.29%
+10.45%
1Y return
-61.93%
-32.06%
Industry
Real Estate
Real Estate
Exchange
NYSE
NYSE
IPO
2019
2015
News (4w)
23
9
Recent ratings
25
10
PHR

Phreesia Inc.

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; appointments solution for online appointments, reminders, and referral tracking; and patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and PRO data for approximately 25 specialties; and life sciences solution to deliver targeted and clinically relevant marketing content to patients, as well as COVID-19 product offerings for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was founded in 2005 and is headquartered in Raleigh, North Carolina.

RELX

RELX PLC PLC

RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.